Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120372) titled 'Research on tigecycline in postoperative analgesia after prostate surgery' on March 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Fengxian District Central Hospital
Condition:
Prostate surgery
Intervention:
Experimental group:At the end of surgery, a loading dose of 1 mg of Tigilidine was administered intravenously, and the patient-controlled analgesia (PCA) pump was started immediately. PCA pump settings: Tigilidine concentration 0.05 mg/ml, bolus dose: 0.05 mg (1 ml), lockout interval: 10 min, continuous infusion: 0.05 mg/h (1 ml/h).
Recruitment Status: Not Recru...